Generic Drug Approvals: April 2004

• Theophylline Extended-Release Tablets 300mg and 450 mg
  Able Laboratories, Inc. Approved: April 30, 2004
• Metolazone Tablets, USP 10 mg
  Roxane Laboratories, Inc. Approved: April 29, 2004
• Ketoconazole Cream 2%
  Altana Inc. Approved: April 28, 2004
• First Time Generic for Fludara for Injection
  Fludarabine Phosphate Injection 25 mg/mL; packaged in 50 mg/2 mL Single-Dose Vials
  Sicor Pharmaceuticals, Inc. Approved: April 28, 2004
• First Time Generic for Neurontin 100 mg
  Gabapentin Tablets 100 mg, 300 mg, and 400 mg
  Ivax Pharmaceuticals, Inc. Approved: April 28, 2004
• First Time Generic for Uniphyl
  Theophylline Extended-Release Tablets 400 mg and 600 mg
  Able Laboratories, Inc. Approved: April 27, 2004
• Methadone Hydrochloride Tablets, USP 5 mg and 10 mg
  Mallinckrodt Inc. Approved: April 27, 2004
• First Time Generic for Brethine Injection
  Terbutaline Sulfate Injection, UAP 1 mg/mL
  Bedford Laboratories Approved: April 23, 2004
• Fosinopril Sodium Tablets 10 mg, 20 mg, and 40 mg
  Eon Labs, Inc. Approved: April 23, 2004
• Fosinopril Sodium Tablets 10 mg, 20 mg, and 40 mg
  Ranbaxy Laboratories Limited Approved: April 23, 2004
• Propafenone Hydrochloride Tablets 150 mg, 225 mg, and 300 mg
  Pliva, Inc. Approved: April 23, 2004
• First Time Generic for Remeron
  Mirtazapine Tablets 7.5 mg, 15 mg, 30 mg, and 45 mg
  Caraco Pharmaceutical Laboratories, Ltd. Approved: April 22, 2004
• First Time Generic for Ovcon-35
  Norethindrone and Ethinyl Estradiol Tablets, USP 0.4 mg/0.035 mg; 21-Day Cycle (Balziva-21 Tablets)
  Barr Laboratories, Inc. Approved: April 22, 2004
• First Time Generic for Ovcon-35
  Norethindrone and Ethinyl Estradiol Tablets, USP 0.4 mg/0.035 mg; 28-Day Cycle (Balziva-28 Tablets)
  Barr Laboratories, Inc. Approved: April 22, 2004
• Cladribine Injection 1 mg/mL; packaged in 10 mL Single-Dose Vials
  American Pharmaceutical Partners, Inc. Approved: April 22, 2004
• Diazepam Injection, USP 5 mg/mL packaged in 5 mg/1 mL and 10 mg/2 mL Single-Dose Vials & 50 mg/mL Multiple-Dose Vials
  Parenta Pharmaceuticals, Inc. Approved: April 15, 2004
• Sotalol Hydrochloride Tablets 80 mg, 120 mg, and 160 mg
  Mutual Pharmaceutical Company, Inc. Approved: April 8, 2004
• First Time Generic for Rebetol
  Ribavirin Capsules 200 mg
  Sandoz, Inc. Approved: April 6, 2004
• First Time Generic for Rebetol
  Ribavirin Capsules 200 mg
  Three Rivers Pharmaceuticals, LLC Approved: April 6, 2004
• First Time Generic for Terazol 3
  Terconazole Vaginal Cream 0.8%
  Taro Pharmaceuticals U.S.A., Inc. Approved: April 6, 2004

Generic Approvals Archive